- Home
- ARMP vs HBIO Comparison
ARMP vs HBIO Comparison
Compare ARMP & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- HBIO
- Stock Information
- Founded
- ARMP 2016
- HBIO 1901
- Country
- ARMP United States
- HBIO United States
- Employees
- ARMP N/A
- HBIO N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- ARMP Health Care
- HBIO Industrials
- Exchange
- ARMP Nasdaq
- HBIO Nasdaq
- Market Cap
- ARMP 73.8M
- HBIO 61.2M
- IPO Year
- ARMP N/A
- HBIO 2000
- Fundamental
- Price
- ARMP $1.58
- HBIO $0.61
- Analyst Decision
- ARMP Strong Buy
- HBIO Buy
- Analyst Count
- ARMP 1
- HBIO 1
- Target Price
- ARMP $7.00
- HBIO $4.50
- AVG Volume (30 Days)
- ARMP 15.2K
- HBIO 377.6K
- Earning Date
- ARMP 03-20-2025
- HBIO 03-12-2025
- Dividend Yield
- ARMP N/A
- HBIO N/A
- EPS Growth
- ARMP N/A
- HBIO N/A
- EPS
- ARMP N/A
- HBIO N/A
- Revenue
- ARMP $5,174,000.00
- HBIO $94,135,000.00
- Revenue This Year
- ARMP $8.43
- HBIO $5.97
- Revenue Next Year
- ARMP N/A
- HBIO $14.52
- P/E Ratio
- ARMP N/A
- HBIO N/A
- Revenue Growth
- ARMP 14.24
- HBIO N/A
- 52 Week Low
- ARMP $1.58
- HBIO $0.56
- 52 Week High
- ARMP $4.25
- HBIO $4.70
- Technical
- Relative Strength Index (RSI)
- ARMP 30.25
- HBIO 24.76
- Support Level
- ARMP $1.63
- HBIO $0.56
- Resistance Level
- ARMP $2.30
- HBIO $0.63
- Average True Range (ATR)
- ARMP 0.15
- HBIO 0.06
- MACD
- ARMP -0.04
- HBIO 0.02
- Stochastic Oscillator
- ARMP 0.00
- HBIO 21.74
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.